However, the expression level of ACOT7, NUAK2, ACTA1, EEF1B22, NMNAT3 and RENBP had no correlation with the overall survival of GBM patients (Figure 6(A,C–F,P)). This evidence concerns the gene ACOT7 and glioblastoma.